Carisma Therapeutics, Inc. Announces Latest Data from Phase 1 Clinical Trial of CT-0508 At 8th Annual CAR-TCR Summit

Carisma Therapeutics Inc. will present findings at the 8th Annual CAR-TCR Summit from its Phase 1 clinical trial of the Company's lead product candidate, CT-0508, a human epidermal growth factor...

Related Keywords

Kima Reiss ,Michael Klichinsky ,Carisma Therapeutics Inc ,Perelman School Of Medicine ,University Of Pennsylvania ,Carisma Therapeutics ,Perelman School ,Chief Scientific Officer ,Markets ,